AI assistant
Sending…
Lexaria Bioscience Corp. — Director's Dealing 2025
Jul 30, 2025
34983_dirs_2025-07-30_e10624d7-7db4-44e2-a08e-15aceae90b1a.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Lexaria Bioscience Corp. (LEXX)
CIK: 0001348362
Period of Report: 2025-07-29
Reporting Person: Carle Vanessa (Secretary)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-29 | common shares | P | 750 | $0.91 | Acquired | 750 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options | $3 | 2026-04-26 | Common Shares (12500) | 12500 | Direct |
| Stock Options | $3 | 2026-06-08 | Common Shares (5000) | 17500 | Direct |
| Stock Options | $3 | 2026-09-01 | Common Shares (10000) | 27500 | Direct |
| Stock Options | $2.91 | 2027-08-29 | Common Shares (12500) | 40000 | Direct |
| Stock Options | $1.15 | 2028-10-26 | Common Shares (10000) | 50000 | Direct |
| Stock Options | $2.36 | 2029-04-26 | Common Shares (10000) | 60000 | Direct |
| Stock Options | $1.04 | 2030-05-15 | Common Shares (15000) | 75000 | Direct |
More from Lexaria Bioscience Corp.
Interim / Quarterly Report
2026
Jul 13
Interim / Quarterly Report
2026
Apr 13
Director's Dealing
2026
Mar 18
Delisting Announcement
2026
Feb 6
Regulatory Filings
2026
Jan 28
Declaration of Voting Results & Voting Rights Announcements
2026
Jan 28
Capital/Financing Update
2026
Jan 14
Delisting Announcement
2026
Jan 14
Interim / Quarterly Report
2026
Jan 13
Capital/Financing Update
2025
Dec 29